1.Sleep in the Greek Mythology
Journal of Sleep Medicine 2019;16(1):21-25
OBJECTIVES: There was also an observation about the “sleep” in the Greek era, which is called the primordial current of modern medicine, which is interpreted as a phenomenon organized by God and appears in various forms in Greek mythology. METHODS: We used the words ‘Greek mythology,’ ‘Sleep,’ ‘God of Sleep,’ ‘Greece,’ and ‘myth’ in English and Korean on Google site for information on sleep in Greek mythology. RESULTS: In Greek mythology, stories appeared about the sleeping god Hypnos, his wife Pasithea, and the dream gods Oneiroi, to explain the mystery of sleep. The various ideas of ancient Greeks' sleep are reflected in legends about Ceyx and Alcyone, Psyche, Endymion, Ariadne, Argos, and Polyphemus. CONCLUSIONS: The images of sleep in Greek mythology that have continued for decades include observations and experiences of mankind. This can be interpreted from a medical point of view as the important significance of sleep on humans.
Dreams
;
History, Modern 1601-
;
Humans
;
Mythology
;
Spouses
2.The History of Parkinson's Disease and Famous Patients
Journal of the Korean Neurological Association 2019;37(1):20-25
BACKGROUND: Parkinson's disease (PD) is one of the most common neurodegenerative diseases. However, the history of PD and famous persons with PD have not been described in detail yet. METHODS: We summarized the history of PD before the first description of James Parkinson's. The four famous patients who were suspected or diagnosed with PD were reviewed through peer-reviewed journals as well as biographies, books, and media. RESULTS: Before the definition of PD was established, there were descriptions of various Parkinsonian symptoms in several literatures. The diagnoses of Adolf Hitler and Na Hyeseok are not certain and we only suspect that they had parkinsonism. The diagnoses of PD of the Pope John Paul II and Muhammad Ali are certain as they had medical records as well as video records that shows progressive deterioration. CONCLUSIONS: Even before James Parkinson, PD have been recognized and described focusing on the bradykinesia and tremor. We should keep in mind that detailed examination as well as transcriptions are important, and that long-term follow-up is needed to document or differentiate PD and its mimics.
Diagnosis
;
Famous Persons
;
Follow-Up Studies
;
Humans
;
Hypokinesia
;
Medical Records
;
Neurodegenerative Diseases
;
Parkinson Disease
;
Parkinsonian Disorders
;
Tremor
4.Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis
Hung Youl SEOK ; Seong Hwa JANG ; Sooyeoun YOU
Journal of Clinical Neurology 2018;14(1):123-125
No abstract available.
Neuromyelitis Optica
5.Isolated Oculomotor Nerve Palsy due to Midbrain Cavernous Malfomation.
Sooyeoun YOU ; Hyun Seok SONG ; Jung Ho HAN ; Ji Soo KIM
Journal of the Korean Neurological Association 2009;27(2):174-175
A 36-year-old previously healthy woman developed diplopia and right-sided ptosis. Neurological examinations were normal except for palsy in the right third cranial nerve with pupil involvement. CT and MRI revealed a cavernous hemangioma with recent bleeding in the right midbrain. This case indicates that midbrain cavernous hemangioma can be a rare cause of isolated pupil involving palsy of the third cranial nerve.
Adult
;
Caves
;
Diplopia
;
Female
;
Hemangioma, Cavernous
;
Hemorrhage
;
Humans
;
Mesencephalon
;
Neurologic Examination
;
Oculomotor Nerve
;
Oculomotor Nerve Diseases
;
Paralysis
;
Pupil
6.Restless Legs Syndrome in Parkinson's Disease Patients: Clinical Features Including Motor and Nonmotor Symptoms
Sooyeoun YOU ; Soo Myeong JEON ; So Young DO ; Yong Won CHO
Journal of Clinical Neurology 2019;15(3):321-327
BACKGROUND AND PURPOSE: We investigated the frequency and clinical features of restless legs syndrome (RLS) in patients with Parkinson's disease (PD). METHODS: This study included 74 PD patients. RLS was diagnosed in face-to-face assessments of all of the subjects based on diagnostic criteria of the International Restless Legs Syndrome Study Group revised in 2003. We analyzed the clinical features of PD patients with and without RLS and compared the data to idiopathic RLS. RESULTS: The frequency of RLS in the cohort was 21.6% (n=16). Two (12.5%) of the patients with RLS were not treated with dopaminergic drugs, while 14 (24.1%) of the 58 patients without RLS received treatment with dopaminergic drugs. Anxiety, depression, and quality of life (QoL) were significantly worst in patients with RLS. PD patients with RLS had significantly worse sleep quality (p=0.003) and worse scores on the cardiovascular subscale of the Scales for Outcomes in Parkinson's Disease for Autonomic Symptoms (p=0.031) compared to those without RLS. In the group of PD patients with RLS, RLS preceding PD onset was related to a lower Hoehn and Yahr stage. CONCLUSIONS: We found that the frequency of RLS in the present patients with PD was higher than that in our previous study of a general population of RLS subjects. Compared to the PD patients without RLS, the present PD patients with RLS suffered from worse sleep quality and QoL, depression, anxiety, and autonomic disturbances, especially those with cardiovascular problems.
Anxiety
;
Cohort Studies
;
Depression
;
Dopamine Agents
;
Humans
;
Parkinson Disease
;
Prevalence
;
Primary Dysautonomias
;
Quality of Life
;
Restless Legs Syndrome
;
Weights and Measures
7.Rapid Eye Movement Sleep Behavior Disorder
Sooyeoun YOU ; Soo Myeong JEON ; Yong Won CHO
Journal of Sleep Medicine 2018;15(1):1-7
Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by sleep interruption or trauma due to abnormal behaviors that occur during REM sleep. The pathophysiology of RBD is known to be a dysfunction of brainstem circuit that causes the loss of skeletal muscle atonia during REM sleep. The diagnosis of RBD is needed to confirm REM sleep without atonia in the polysomnography. The management of RBD includes not only drug treatment, but also to prevent injury from RBD and to follow-up on neurodegenerative diseases that may occur later. RBD is thought to be a prodromal stage of neurodegenerative disease associated with α-synucleoinopathy, such as Parkinson's Disease or multiple system atrophy. This article reviews the symptoms, epidemiology, diagnosis and treatment of RBD, the relevance of neurodegenerative diseases, and recent research trends.
Brain Stem
;
Diagnosis
;
Epidemiology
;
Follow-Up Studies
;
Multiple System Atrophy
;
Muscle, Skeletal
;
Neurodegenerative Diseases
;
Parasomnias
;
Parkinson Disease
;
Polysomnography
;
Prodromal Symptoms
;
REM Sleep Behavior Disorder
;
Sleep, REM
8.Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson's Disease: Therapeutic and Adverse Effects.
Ho Sung RYU ; Mi Sun KIM ; Sooyeoun YOU ; Mi Jung KIM ; Young Jin KIM ; Juyeon KIM ; Kiju KIM ; Sun Ju CHUNG
Journal of Movement Disorders 2017;10(2):80-86
OBJECTIVE: To compare the therapeutic and adverse effects of globus pallidus interna (GPi) and subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of advanced Parkinson's disease (PD). METHODS: We retrospectively analyzed the clinical data of patients with PD who underwent GPi (n = 14) or STN (n = 28) DBS surgery between April 2002 and May 2014. The subjects were matched for age at surgery and disease duration. The Unified Parkinson's Disease Rating Scale (UPDRS) scores and levodopa equivalent dose (LED) at baseline and 12 months after surgery were used to assess the therapeutic effects of DBS. Adverse effects were also compared between the two groups. RESULTS: At 12 months, the mean changes in the UPDRS total and part I–IV scores did not differ significantly between the two groups. However, the subscores for gait disturbance/postural instability and dyskinesia were significantly more improved after GPi DBS than those after STN DBS (p = 0.024 and 0.016, respectively). The LED was significantly more reduced in patients after STN DBS than that after GPi DBS (p = 0.004). Serious adverse effects did not differ between the two groups (p = 0.697). CONCLUSION: The patients with PD showed greater improvement in gait disturbance/postural instability and dyskinesia after GPi DBS compared with those after STN DBS, although the patients had a greater reduction in LED after STN DBS. These results may provide useful information for optimal target selection for DBS in PD.
Deep Brain Stimulation*
;
Dyskinesias
;
Gait
;
Globus Pallidus
;
Humans
;
Levodopa
;
Parkinson Disease*
;
Retrospective Studies
;
Subthalamic Nucleus
;
Therapeutic Uses
9.Hand Tremor Questionnaire: A Useful Screening Tool for Differentiating Patients with Hand Tremor between Parkinson's Disease and Essential Tremor.
Kyum Yil KWON ; Ho Sung RYU ; Hye Mi LEE ; Mi Jung KIM ; Hae Won SHIN ; Hee Kyung PARK ; Sooyeoun YOU ; Young Hee SUNG ; Sun Ju CHUNG ; Seong Beom KOH
Journal of Clinical Neurology 2018;14(3):381-386
BACKGROUND AND PURPOSE: Hand tremor is one of the most frequent symptoms in movement disorders, and differential diagnoses for hand tremor include Parkinson's disease (PD) and essential tremor (ET). However, accurately differentiating between PD and ET in clinical practice remains challenging in patients presenting with hand tremor. We investigated whether a questionnaire-based survey could be useful as a screening tool in patients with hand tremor. METHODS: A questionnaire related to hand tremor consisting of 12 items was prospectively applied to patients with PD or ET in three movement-disorder clinics. Each question was analyzed, and a query-based scoring system was evaluated for differentiating hand tremors between PD and ET. RESULTS: This study enrolled 24 patients with PD and 25 patients with ET. Nine of the 12 questions differed significantly between PD and ET: 1 about resting tremor, 4 questions about action tremor, and 4 about asymmetry. A receiver operating characteristics curve analysis revealed that the 9-item questionnaire showed a good discrimination ability, with a sensitivity of 88% and a specificity of 84%. CONCLUSIONS: The developed Hand Tremor Questionnaire might be a good screening tool for hand tremors in patients with PD and ET.
Diagnosis, Differential
;
Discrimination (Psychology)
;
Essential Tremor*
;
Hand*
;
Humans
;
Mass Screening*
;
Movement Disorders
;
Parkinson Disease*
;
Prospective Studies
;
ROC Curve
;
Sensitivity and Specificity
;
Tremor*
10.Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep
Young Hee SUNG ; Hee Jin KIM ; Seong Beom KOH ; Joong Seok KIM ; Sang Jin KIM ; Sang Myung CHEON ; Jin Whan CHO ; Yoon Joong KIM ; Hyeo Il MA ; Mee Young PARK ; Jong Sam BAIK ; Phil Hyu LEE ; Sun Ju CHUNG ; Jong Min KIM ; In Uk SONG ; Han Joon KIM ; Ji Young KIM ; Do Young KWON ; Jae Hyeok LEE ; Jee Young LEE ; Ji Seon KIM ; Ji Young YUN ; Jin Yong HONG ; Mi Jung KIM ; Jinyoung YOUN ; Ji Sun KIM ; Eung Seok OH ; Hui Jun YANG ; Won Tae YOON ; Sooyeoun YOU ; Kyum Yil KWON ; Hyung Eun PARK ; Su Yun LEE ; Younsoo KIM ; Hee Tae KIM ; Tae Beom AHN
Journal of Korean Medical Science 2018;33(2):e14-
BACKGROUND: Sleep problems commonly occur in patients with Parkinson's disease (PD), and are associated with a lower quality of life. The aim of the current study was to translate the English version of the Scales for Outcomes in Parkinson's Disease-Sleep (SCOPA-S) into the Korean version of SCOPA-S (K-SCOPA-S), and to evaluate its reliability and validity for use by Korean-speaking patients with PD. METHODS: In total, 136 patients with PD from 27 movement disorder centres of university-affiliated hospitals in Korea were enrolled in this study. They were assessed using SCOPA, Hoehn and Yahr Scale (HYS), Unified Parkinson's Disease Rating Scale (UPDRS), Parkinson's Disease Sleep Scale 2nd version (PDSS-2), Non-motor Symptoms Scale (NMSS), Montgomery Asberg Depression Scale (MADS), 39-item Parkinson's Disease Questionnaire (PDQ39), Neurogenic Orthostatic Hypotension Questionnaire (NOHQ), and Rapid Eye Movement Sleep Behaviour Disorder Questionnaire (RBDQ). The test-retest reliability was assessed over a time interval of 10–14 days. RESULTS: The internal consistency (Cronbach's α-coefficients) of K-SCOPA-S was 0.88 for nighttime sleep (NS) and 0.75 for daytime sleepiness (DS). Test-retest reliability was 0.88 and 0.85 for the NS and DS, respectively. There was a moderate correlation between the NS sub-score and PDSS-2 total score. The NS and DS sub-scores of K-SCOPA-S were correlated with motor scale such as HYS, and non-motor scales such as UPDRS I, UPDRS II, MADS, NMSS, PDQ39, and NOHQ while the DS sub-score was with RBDQ. CONCLUSION: The K-SCOPA-S exhibited good reliability and validity for the assessment of sleep problems in the Korean patients with PD.
Depression
;
Humans
;
Hypotension, Orthostatic
;
Korea
;
Movement Disorders
;
Parkinson Disease
;
Quality of Life
;
Reproducibility of Results
;
Sleep, REM
;
Weights and Measures